- Previous Close
6.140 - Open
6.100 - Bid 5.910 x --
- Ask 5.950 x --
- Day's Range
5.900 - 6.100 - 52 Week Range
5.740 - 21.800 - Volume
178,300 - Avg. Volume
448,380 - Market Cap (intraday)
878.455M - Beta (5Y Monthly) -0.28
- PE Ratio (TTM)
8.87 - EPS (TTM)
0.670 - Earnings Date --
- Forward Dividend & Yield 0.30 (5.05%)
- Ex-Dividend Date Jun 23, 2025
- 1y Target Est
--
Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company's product portfolio comprises of proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry, and pediatric ophthalmology. Gaush Meditech Ltd. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
www.gaush.comRecent News: 2407.HK
View MorePerformance Overview: 2407.HK
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2407.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2407.HK
View MoreValuation Measures
Market Cap
878.45M
Enterprise Value
914.03M
Trailing P/E
8.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.57
Price/Book (mrq)
0.52
Enterprise Value/Revenue
0.60
Enterprise Value/EBITDA
4.45
Financial Highlights
Profitability and Income Statement
Profit Margin
6.47%
Return on Assets (ttm)
4.49%
Return on Equity (ttm)
5.39%
Revenue (ttm)
1.43B
Net Income Avi to Common (ttm)
92.39M
Diluted EPS (ttm)
0.670
Balance Sheet and Cash Flow
Total Cash (mrq)
518.99M
Total Debt/Equity (mrq)
34.77%
Levered Free Cash Flow (ttm)
--